VIR BIOTECHNOLOGY, I

VIR
Delayed Quote. Delayed  - 06/11 04:00:00 pm
45.53USD -1.94%

Vir Biotechnology : GlaxoSmithKline's SARS-CoV-2 Antibody Accepted for Rolling Review at European Medicines Agency

05/07/2021 | 06:18am
MarketScreener.com
This article is reserved for subscribers
A "one-stop shopping" service for investors
The best opportunities, portfolios, and screeners
Discover